Yiming Bio

以明生物

Yiming Bio

Biotech/Healthcare

Yiming Biotech is a clinical-stage biopharmaceutical company focused on cancer immunotherapy. It develops novel myeloid-cell immune checkpoint inhibitors for cancer patients.

Latest round: Series B Extension (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-01-01